Warm antibody autoimmune hemolytic anemia

Hematology (United States)

Volumn 2016, Issue 1, 2016, Pages 690-697

  Kalfa, Theodosia A ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; COOMBS TEST; DELAYED DIAGNOSIS; HUMAN; IDIOPATHIC DISEASE; IMMUNE DYSREGULATION; IMMUNOPATHOGENESIS; WARM AUTOIMMUNE HEMOLYTIC ANEMIA; ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; FEMALE; GENETICS; IMMUNOLOGY; MALE;

ADULT; ANEMIA, HEMOLYTIC, AUTOIMMUNE; FEMALE; HUMANS; MALE;

EID: 85017483714     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2016.1.690     Document Type: Article

References (56)

1. Franco RS Measurement of red cell lifespan and aging. Transfus Med Hemother. 2012; 39(5): 302-307.
2. Garratty G. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction? Transfus Med. 2008; 18(6): 321-334.
3. Barcellini W. New insights in the pathogenesis of autoimmune hemolytic anemia. Transfus Med Hemother. 2015; 42(5): 287-293.
4. Coombs RR, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. Br J Exp Pathol. 1945; 26: 255-266.
5. Zantek ND, Koepsell SA, Tharp DR Jr, Cohn CS. The direct antiglobulin test: a critical step in the evaluation of hemolysis. Am J Hematol. 2012; 87(7): 707-709.
6. Barros MM, Blajchman MA, Bordin JO. Warm autoimmune hemolytic anemia: recent progress in understanding the immunobiology and the treatment. Transfus Med Rev. 2010; 24(3): 195-210.
7. Bass GF, Tuscano ET, Tuscano JM. Diagnosis and classification of autoimmune hemolytic anemia. Autoimmun Rev. 2014; 13(4-5): 560-564.
8. Michel M. Classification and therapeutic approaches in autoimmune hemolytic anemia: an update. Expert Rev Hematol. 2011; 4(6): 607-618.
9. Sokol RJ, Hewitt S, Stamps BK. Autoimmune haemolysis: an 18-year study of 865 cases referred to a regional transfusion centre. Br Med J (Clin Res Ed). 1981; 282(6281): 2023-2027.
10. Aladjidi N, Leverger G, Leblanc T, et al.; Centre de Référence National des Cytopénies Auto-immunes de l'Enfant (CEREVANCE). New insights into childhood autoimmune hemolytic anemia: a French national observational study of 265 children. Haematologica. 2011; 96(5): 655-663.
11. Sokol RJ, Hewitt S, Stamps BK, Hitchen PA. Autoimmune haemolysis in childhood and adolescence. Acta Haematol. 1984; 72(4): 245-257.
12. Berentsen S. Role of complement in autoimmune hemolytic anemia. Transfus Med Hemother. 2015; 42(5): 303-310.
13. Ma K, Caplan S. Refractory IgG warm autoimmune hemolytic anemia treated with eculizumab: a novel application of anticomplement therapy. Case Rep Hematol. 2016; 2016: 9181698.
14. LoBuglio AF, Cotran RS, Jandl JH. Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science. 1967; 158(3808): 1582-1585.
15. Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol. 2000; 111(2): 452-460.
16. Ahmad E, Elgohary T, Ibrahim H. Naturally occurring regulatory T cells and interleukins 10 and 12 in the pathogenesis of idiopathic warm autoimmune hemolytic anemia J Investig Allergol Clin Immunol. 2011; 21(4): 297-304.
17. Evans RS, Weiser RS. The serology of autoimmune hemolytic disease; observations on forty-one patients. AMA Arch Intern Med. 1957; 100(3): 371-399.
18. Segel GB, Lichtman MA. Direct antiglobulin ("Coombs") test-negative autoimmune hemolytic anemia: a review. Blood Cells Mol Dis. 2014; 52(4): 152-160.
19. Kamesaki T, Toyotsuji T, Kajii E. Characterization of direct antiglobulin test-negative autoimmune hemolytic anemia: a study of 154 cases. Am J Hematol. 2013; 88(2): 93-96.
20. Kajii E, Omi T, Miura Y, Ikemoto S. [A new approach for diagnosis of autoimmune hemolytic anemia]. Rinsho Ketsueki. 1994; 35(4): 336-340.
21. Gilliland BC, Baxter E, Evans RS. Red-cell antibodies in acquired hemolytic anemia with negative antiglobulin serum tests. N Engl J Med. 1971; 285(5): 252-256.
22. Chaudhary R, Das SS, Gupta R, Khetan D. Application of flow cytometry in detection of red-cell-bound IgG in Coombs-negative AIHA. Hematology. 2006; 11(4): 295-300.
23. Fayek MH, Saad AA, Eissa DG, Tawfik LM, Kamal G Role of gel test and flow cytometry in diagnosis of Coombs' negative autoimmune haemolytic anaemia. Int J Lab Hematol. 2012; 34(3): 311-319.
24. Sokol RJ, Booker DJ, Stamps R, Jalihal S, Paul B. Direct Coombs test-negative autoimmune hemolytic anemia and low-affinity IgG class antibodies. Immunohematology. 1997; 13(4): 115-118.
25. Sokol RJ, Booker DJ, Stamps R, Booth JR. Autoimmune hemolytic anemia due to IgA class autoantibodies. Immunohematology. 1996; 12(1): 14-19.
26. Leger RM, Co A, Hunt P, Garrity G Attempts to support an immune etiology in 800 patients with direct antiglobulin test-negative hemolytic anemia. Immunohematology. 2010; 26(4): 156-160.
27. Arndt PA, Leger RM, Garratty G Serologic findings in autoimmune hemolytic anemia associated with immunoglobulin M warm autoantibodies. Transfusion. 2009; 49(2): 235-242.
28. Biagi E, Assali G, Rossi F, Jankovic M, Nicolini B, Balduzzi A. A persistent severe autoimmune hemolytic anemia despite apparent direct antiglobulin test negativization. Haematologica. 1999; 84(11): 1043-1045.
29. Karafin MS, Denomme GA, Schanen M, Gottschall JL. Clinical and reference lab characteristics of patients with suspected direct antiglobulin test (DAT)-negative immune hemolytic anemia. Immunohematology. 2015; 31(3): 108-115.
30. Sachs UJ, Röder L, Santoso S, Bein G Does a negative direct antiglobulin test exclude warm autoimmune haemolytic anaemia? A prospective study of 504 cases. Br J Haematol. 2006; 132(5): 655-656.
31. Evans RS, Takahashi K, Duane RT, Payne R, Liu C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med. 1951; 87(1): 48-65.
32. Miano M. How I manage Evans Syndrome and AIHA cases in children. Br J Haematol. 2016; 172(4): 524-534.
33. Ghosh S, Seidel MG Editorial: current challenges in immune and other acquired cytopenias of childhood. Front Pediatr. 2016; 4: 3.
34. Seidel MG Autoimmune and other cytopenias in primary immunodeficiencies: pathomechanisms, novel differential diagnoses, and treatment. Blood. 2014; 124(15): 2337-2344.
35. Teachey DT New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome. Curr Opin Pediatr. 2012; 24(1): 1-8.
36. Rao VK Approaches to managing autoimmune cytopenias in novel immunological disorders with genetic underpinnings like autoimmune lymphoproliferative syndrome. Front Pediatr. 2015; 3: 65.
37. Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol. 2010; 148(2): 205-216.
38. Oliveira JB The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr. 2013; 25(6): 722-729.
39. Bride KL, Vincent T, Smith-Whitley K, et al. Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial. Blood. 2016; 127(1): 17-28.
40. Price S, Shaw PA, Seitz A, et al. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations. Blood. 2014; 123(13): 1989-1999.
41. Neven B, Bruneau J, Stolzenberg MC, et al. Defective anti-polysaccharide response and splenic marginal zone disorganization in ALPS patients. Blood. 2014; 124(10): 1597-1609.
42. Lechner K, Jäger U. How I treat autoimmune hemolytic anemias in adults. Blood. 2010; 116(11): 1831-1838.
43. Zanella A, Barcellini W. Treatment of autoimmune hemolytic anemias. Haematologica. 2014; 99(10): 1547-1554.
44. Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014; 124(19): 2930-2936.
45. King KE, Ness PM. Treatment of autoimmune hemolytic anemia. Semin Hematol. 2005; 42(3): 131-136.
46. Petz LD A physician's guide to transfusion in autoimmune haemolytic anaemia. Br J Haematol. 2004; 124(6): 712-716.
47. Murphy S, LoBuglio AF. Drug therapy of autoimmune hemolytic anemia. Semin Hematol. 1976; 13(4): 323-334.
48. Patel VL, Mahévas M, Lee SY, et al. Outcomes 5 years after response to rituximab therapy in children and adults with immune thrombocytopenia. Blood. 2012; 119(25): 5989-5995.
49. Diwakar L, Gorrie S, Richter A, et al. Does rituximab aggravate preexisting hypogammaglobulinaemia? J Clin Pathol. 2010; 63(3): 275-277.
50. Cooper N, Davies EG, Thrasher AJ. Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin. Br J Haematol. 2009; 146(1): 120-122.
51. Reynaud Q, Durieu I, Dutertre M, et al. Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies. Autoimmun Rev. 2015; 14(4): 304-313.
52. Ahn YS, Harrington WJ, Mylvaganam R, Ayub J, Pall LM. Danazol therapy for autoimmune hemolytic anemia. Ann Intern Med. 1985; 102(3): 298-301.
53. Sobota A, Neufeld EJ, Lapsia S, Bennett CM. Response to mercaptopurine for refractory autoimmune cytopenias in children. Pediatr Blood Cancer. 2009; 52(1): 80-84.
54. Snowden JA, Saccardi R, Allez M, et al.; EBMT Autoimmune Disease Working Party (ADWP); Paediatric Diseases Working Party (PDWP). Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant. 2012; 47(6): 770-790.
55. Kulpa J, Skrabs C, Simanek R, et al. Probability of remaining in unsustained complete remission after steroid therapy withdrawal in patients with primary warm-antibody reactive autoimmune hemolytic anemia. Wien Klin Wochenschr. 2016; 128(7-8): 234-237.
56. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010; 115(2): 168-186.